UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth

Cancer research (Chicago, Ill.), 2009-02, Vol.69 (4), p.1536-1544

2009

Link zum Volltext

Verfügbarkeit prüfen

Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17

Anti-cancer drugs, 2012-01, Vol.23 (1), p.119-130

2012

Link zum Volltext

Verfügbarkeit prüfen

Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo

Cancer science, 2007-02, Vol.98 (2), p.219-225

2007

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents

Bioorganic & medicinal chemistry letters, 2005-07, Vol.15 (14), p.3328-3332

2005

Link zum Volltext

Verfügbarkeit prüfen

Anti-tumour activity of CS-7017, a selective peroxisome proliferator-activated receptor gamma agonist of thiazolidinedione class, in human tumour xenografts and a syngeneic tumour implant model

European journal of cancer (1990), 2008-08, Vol.44 (12), p.1734-1743

2008

Link zum Volltext

Verfügbarkeit prüfen

Troglitazone can prevent development of type 1 diabetes induced by multiple low-dose streptozotocin in mice

Life sciences (1973), 1999, Vol.65 (12), p.1287-1296

1999

Link zum Volltext

Verfügbarkeit prüfen

Collagen secretion and growth of mesangial cells require geranylgeranylpyrophosphate

Kidney international, 1999-02, Vol.55 (2), p.520-528

1999

Link zum Volltext

Verfügbarkeit prüfen

CS‐706, a novel cyclooxygenase‐2 selective inhibitor, prolonged the survival of tumor‐bearing mice when treated alone or in combination with anti‐tumor chemotherapeutic agents

International journal of cancer, 2008-03, Vol.122 (6), p.1384-1390

2008

Link zum Volltext

Verfügbarkeit prüfen

Abstract B133: Antitumor effects of novel high-hydrophilic and non-ATP-competitive MEK1/2 inhibitor SMK-17

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.B133-B133

2011

Link zum Volltext

Verfügbarkeit prüfen

TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice

The Journal of immunology (1950), 1995-11, Vol.155 (10), p.4926

1995

Link zum Volltext

Verfügbarkeit prüfen

The high affinity peroxisome proliferator‐activated receptor‐gamma agonist RS5444 inhibits both initiation and progression of colon tumors in azoxymethane‐treated mice

International journal of cancer, 2008-09, Vol.123 (5), p.991-997

2008

Link zum Volltext

Verfügbarkeit prüfen

HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype

Cancer research (Chicago, Ill.), 1999-11, Vol.59 (22), p.5695-5703

1999

Link zum Volltext

Verfügbarkeit prüfen

Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo

Cancer science, 2006-12, p.61208004037001-?

2006

Link zum Volltext

Verfügbarkeit prüfen

Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation

Kidney international, 1999-07, Vol.56 (S71), p.S97-S100

1999

Link zum Volltext

Verfügbarkeit prüfen

Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro

Immunopharmacology, 1996-08, Vol.34 (1), p.51-61

1996

Link zum Volltext

Verfügbarkeit prüfen

Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-?-d-ARABINO-Pentofuranosyl) cytosine) and itsN4-palmitoyl derivative (CS-682)

International journal of cancer, 1999-07, Vol.82 (2), p.226-236

1999

Link zum Volltext

Verfügbarkeit prüfen

Antitumor activity and novel DNA‐self‐strand‐breaking mechanism of CNDAC (1‐(2‐C‐cyano‐2‐deoxy‐β‐d‐ARABINO‐Pentofuranosyl) cytosine) and its N4‐palmitoyl derivative (CS‐682)

International journal of cancer, 1999-07, Vol.82 (2), p.226-236

1999

Link zum Volltext

Verfügbarkeit prüfen

Effect of Captopril Treatment on Proteinuria in NZB/NZW F1 Hybrid Mice

The Japanese Journal of Pharmacology, 1988, Vol.46(1), pp.86-89

1988

Link zum Volltext

Verfügbarkeit prüfen

Effect of Captopril Treatment on Proteinuria in NZB/NZW F1 Hybrid Mice

Japanese journal of pharmacology, 1988, Vol.46 (1), p.86-89

1988

Link zum Volltext

Verfügbarkeit prüfen

STRAIN DIFFERENCES IN THE ANTITUMOR ACTIVITY OF AN IMMUNOPOTENTIATOR, NOCARDIA RUBRA CELL-WALL SKELETON, IN B10 CONGENIC AND RECOMBINANT MICE

Japanese Journal of Cancer Research GANN, 1985, Vol.76(5), pp.400-413

1985

Link zum Volltext

Verfügbarkeit prüfen

抗腫瘍薬の新しい方向 : COX-2選択的阻害,PPARγアゴニストをキーワードとして(最前線)

ファルマシア, 2003/06/01, Vol.39(6), pp.517-521

2003

Link zum Volltext

Verfügbarkeit prüfen

Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms

Cellular immunology, 1989-10, Vol.123 (1), p.134-147

1989

Link zum Volltext

Verfügbarkeit prüfen

The Interaction of Lysophosphatidylcholine with Protein-Containing Liposomes1

Journal of biochemistry (Tokyo), 1981-07, Vol.90 (3), p.657-663

1981

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the immune response to tumors by a novel synthetic compound, (4R)-3-benzoyl-N-[(1R)-1-phenylethyl]-4-thiazolidinecarboxamide (RS-0481)

Cancer Immunology Immunotherapy, 1991-03, Vol.33 (2), p.71-79

1991

Link zum Volltext

Verfügbarkeit prüfen

Suppressor cells in levamisole-treated mice: A possible role of T-cell-mediated feedback suppression in the drug-induced suppression of the humoral immune response

Immunopharmacology, 1983-12, Vol.6 (4), p.279-287

1983

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(35)

Sprache

Englisch
(28)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Animals
(16)
Biological And Medical Sciences
(15)
Mice
(15)
Medical Sciences
(13)
Female
(12)
Humans
(11)
Oncology
(8)
Pharmacology. Drug Treatments
(7)
Cell Line, Tumor
(6)
Pharmacology & Pharmacy
(6)
Tumors
(6)
Antineoplastic Agents - Pharmacology
(4)
Antineoplastic Agents - Therapeutic Use
(4)
Cells, Cultured
(4)
Immunology
(4)
Antineoplastic Agents
(3)
Cancer Research
(3)
Cell Proliferation - Drug Effects
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth

Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17

Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo

Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents

Anti-tumour activity of CS-7017, a selective peroxisome proliferator-activated receptor gamma agonist of thiazolidinedione class, in human tumour xenografts and a syngeneic tumour implant model

Troglitazone can prevent development of type 1 diabetes induced by multiple low-dose streptozotocin in mice

Collagen secretion and growth of mesangial cells require geranylgeranylpyrophosphate

CS‐706, a novel cyclooxygenase‐2 selective inhibitor, prolonged the survival of tumor‐bearing mice when treated alone or in combination with anti‐tumor chemotherapeutic agents

Abstract B133: Antitumor effects of novel high-hydrophilic and non-ATP-competitive MEK1/2 inhibitor SMK-17

TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice

The high affinity peroxisome proliferator‐activated receptor‐gamma agonist RS5444 inhibits both initiation and progression of colon tumors in azoxymethane‐treated mice

HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype

Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo

Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation

Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro

Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-?-d-ARABINO-Pentofuranosyl) cytosine) and itsN4-palmitoyl derivative (CS-682)

Antitumor activity and novel DNA‐self‐strand‐breaking mechanism of CNDAC (1‐(2‐C‐cyano‐2‐deoxy‐β‐d‐ARABINO‐Pentofuranosyl) cytosine) and its N4‐palmitoyl derivative (CS‐682)

Effect of Captopril Treatment on Proteinuria in NZB/NZW F1 Hybrid Mice

Effect of Captopril Treatment on Proteinuria in NZB/NZW F1 Hybrid Mice

STRAIN DIFFERENCES IN THE ANTITUMOR ACTIVITY OF AN IMMUNOPOTENTIATOR, NOCARDIA RUBRA CELL-WALL SKELETON, IN B10 CONGENIC AND RECOMBINANT MICE

抗腫瘍薬の新しい方向 : COX-2選択的阻害,PPARγアゴニストをキーワードとして(最前線)

Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms

The Interaction of Lysophosphatidylcholine with Protein-Containing Liposomes1

Modulation of the immune response to tumors by a novel synthetic compound, (4R)-3-benzoyl-N-[(1R)-1-phenylethyl]-4-thiazolidinecarboxamide (RS-0481)

Suppressor cells in levamisole-treated mice: A possible role of T-cell-mediated feedback suppression in the drug-induced suppression of the humoral immune response

Suchergebnisse filtern